US Patent Issued to BIOHENG THERAPEUTICS on July 28 for "CD7-targeting humanized antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,312, issued on July 28, was assigned to BIOHENG THERAPEUTICS Ltd. (Grand Cayman, Cayman Islands).

"CD7-targeting humanized antibody and use thereof" was invented by Yali Zhou (Nanjing, China), Xiaoyan Jiang (Nanjing, China), Gong Chen (Nanjing, China), Jiangtao Ren (Nanjing, China), Xiaohong He (Nanjing, China), Yanbin Wang (Nanjing, China) and Lu Han (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a CD7-targeting humanized antibody, and a multispecific antibody, chimeric antigen receptor, antibody conjugate, pharmaceutical composition, and kit comprising the CD7-targeting humanized antibody, and a use t...